Clinical Trial Update: Duration of Surfactant Administration and Impact on Stabilisation of Vital Parameters in Very Preterm Neonates: 1 Minutes Versus 5 Minutes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating whether delivering surfactant for 1 minute versus 5 minutes improves stabilization of vital signs in very preterm neonates wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Respiratory Distress Syndrome
• Surfactant Deficiency Neonatal

Drugs mentioned

• Surfactant (neonatal) (surfactant)

Snippet

Sponsor: Medical University of Graz | Conditions: Neonates and Preterm Infants, Infant Respiratory Distress Syndrome | Phase 4 | Status: NOT_YET_RECRUITING